Project 5 Report15Financial ProjectionsSome of MediCorp’s top competitors of medical devices in the German market include Geratherm Medical AG, Itamar Medical Ltd, GlaxoSmithKline PLC, Cea Medical Manufacturing Inc, and Avita Medical Ltd. For the fiscal year 2018, the total revenue of each company is as follows: Geratherm Medical AG - $24,630,000.00; Itamar Medical Ltd. - $26,110,000.00; GlaxoSmithKline PLC - $41,140,000.00; Cea Medical Manufacturing Inc - $26,610,000.00; Avita Medical Ltd. - $25,330,000.00 (Geratherm Medical AG, 2020). (See Appendices E for “The Total Revenue of Each Company, 2018”). Currently, the total value of themedical device segment in the German market is at $4.3 Billion.The global nebulizer market is valued at $720 million USD in 2018, $926.1 million USD in 2019. It is projected to reach $972.45 million USD in 2020, and estimated to increase to $1.44 billion USD by the end of 2024, growing at a Compound Annual Growth Rate (CAGR) of 4.02%during 2019-2024. Although not reporting exclusively on nebulizers, Business Insight has reported that Germany’s respiratory device market was valued at around $1.1 billion USD in 2018 and is estimated to grow at a CAGR of 6.5% during the forecast period of 2019 to 2025.